| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H11NO2 |
| Molecular Weight | 153.1784 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCOC(=O)C(=C)C#N
InChI
InChIKey=JJJFUHOGVZWXNQ-UHFFFAOYSA-N
InChI=1S/C8H11NO2/c1-3-4-5-11-8(10)7(2)6-9/h2-5H2,1H3
| Molecular Formula | C8H11NO2 |
| Molecular Weight | 153.1784 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Enbucrilate (also known as n-butyl-cyanoacrylate, n-BCA) is an adhesive substance, which is used under different trade names (Histoacryl, 3M Liquid Bandage, etc) as an OTC medication for strong and secure wound closure. In 2000 FDA approved enbucrilate (TRUFILL n-BCA Liquid Embolic System) for presurgical embolization of cerebral arteriovenous malformations.
Approval Year
Doses
PubMed
Sample Use Guides
Topical: Apply the medication to the wound very sparingly, either as minute drops or as a very thin film along the edges of the wound. Infusion: A mixture of enbucrilate with Ethiodized Oil and tantalum powder (enbucrilate/Ethiodized oil ratio is 3:1, 2:1, 1:1, 1:2) is administered via a catheter.
Route of Administration:
Other
